CD123-directed T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123-directed T-cell therapy, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) [Phase 1]